Related Experiment Video
Updated: Aug 15, 2026

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
Published on: August 18, 2015
Thrombophilia and first arterial ischaemic stroke: a systematic review
S Haywood1, R Liesner, S Pindora
1Neurosciences Unit, Institute of Child Health, University College, London, UK.
Insights
Thrombophilia, or blood clotting disorders, are more common in children experiencing their first arterial ischemic stroke (AIS). Protein C deficiency and MTHFR C677T mutations showed significantly higher prevalence in these pediatric patients.
Area of Science:
- Pediatric Neurology
- Hematology
- Genetics
Background:
- Arterial ischemic stroke (AIS) in children is a significant concern.
- Thrombophilia, a predisposition to blood clots, is a suspected risk factor for AIS.
- Understanding the prevalence of specific thrombophilic conditions in pediatric AIS is crucial for risk assessment.
Purpose of the Study:
- To systematically review the literature on the prevalence of thrombophilia in children with a first arterial ischemic stroke (AIS).
Main Methods:
- Systematic review of case-control studies.
- Included data on protein C, S, and antithrombin deficiencies, activated protein C resistance (APCr), elevated homocysteine, Factor V 1691 GA, Prothrombin 20210GA, and MTHFR C677T mutations.
- Meta-analyses were performed to calculate pooled odds ratios (OR).
Main Results:
- 18 studies met inclusion criteria, analyzing 3235 patients and 9019 controls.
- Significantly higher prevalence of protein C deficiency (OR 6.49) and MTHFR C677T mutation (OR 1.70) in children with AIS compared to controls.
- Other factors like protein S deficiency, AT deficiency, APCr, FV1691 GA, PT20210GA, and elevated homocysteine were also more common but not statistically significant.
Conclusions:
- Protein C deficiency and MTHFR C677T mutation are significantly associated with first arterial ischemic stroke in children.
- Further research is needed to establish the prognostic and recurrence implications of thrombophilia in pediatric AIS.
- Clinical recommendations for investigation and treatment require further evidence.
Aims:
To undertake a systematic review of the literature reporting the prevalence of thrombophilia in children with a first arterial ischaemic stroke (AIS).
Methods:
Systematic review of case-control studies reporting data for prevalence of protein C, S, and antithrombin (AT) deficiencies, activated protein C resistance (APCr), total plasma homocysteine >95th centile, the thrombophilic mutations factor V1691 GA, prothrombin 20210GA, and MTHFR C677T in children with first, radiologically confirmed, AIS.
Results:
Of 1437 potentially relevant citations, 18 met inclusion criteria. A total of 3235 patients and 9019 controls had been studied. Results of meta-analyses were expressed as pooled odds ratios (OR) relating the prevalence of the thrombophilic condition in children with AIS to that in controls. The pooled OR (and 95% CI) were: protein C deficiency, 6.49 (2.96 to 14.27); protein S deficiency, 1.14 (0.34 to 3.80); AT deficiency, 1.02 (0.28 to 3.67); APCr, 1.34 (0.16 to 11.52); FV1691 GA, 1.22 (0.80 to 1.87); PT20210GA, 1.10 (0.51 to 2.34); MTHFR C677T, 1.70 (1.23 to 2.34); and total plasma homocysteine >95th centile, 1.36 (0.53 to 3.51). There was no statistical heterogeneity within these data.
Conclusions:
All factors examined were more common in children with first AIS than in controls, and significantly so for protein C deficiency and the MTHFR C677T mutation. The implications of thrombophilia for prognosis and recurrence need to be established before clinical recommendations can be made regarding investigation and treatment of children with AIS.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis I: Introduction
Venous Thrombosis III: Interprofessional Care
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology

